Melphalan - Latest Advances

An Azoreductase-Activated Self-monitoring Prodrug for Chemiluminescence Imaging and Safe Chemotherapy Breast Cancer.

Journal: Journal of medicinal chemistry

Published: January 13, 2026

High Cytotoxicity of Ruthenium(II) and Gold(I) Bimetallic Complexes and Its Precursors.

Journal: Inorganic chemistry

Published: January 06, 2026

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 24, 2025

Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.

Journal: Immuno-oncology technology

Published: December 09, 2025

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: December 07, 2025

How to approach the high-risk myeloma from induction through relapse?

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Effect and safety of a conditioning regimen with chidamide and BEAM for autologous hematopoietic stem cell transplantation in lymphoma

Journal: Zhonghua nei ke za zhi

Published: December 03, 2025

Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response.

Journal: Investigative ophthalmology & visual science

Published: December 03, 2025

NGS-based monitoring of secondary acute lymphoblastic leukemia dynamics following lenalidomide maintenance in multiple myeloma patients.

Journal: Leukemia & lymphoma

Published: November 19, 2025

Busulfan and melphalan (Bu-Mel) versus carboplatin, etoposide, and melphalan (CEM) conditioning regimens for autologous haematopoietic stem cell transplant in children and young adults with high-risk neuroblastoma.

Journal: The Cochrane database of systematic reviews

Published: November 13, 2025

The efficacy of topotecan versus topotecan combined with melphalan in the treatment of vitreous seeds in retinoblastoma

Journal: [Zhonghua yan ke za zhi] Chinese journal of ophthalmology

Published: November 11, 2025

Tandem conditioning-based myeloablative HSCT for pediatric patients with refractory myeloid leukemias.

Journal: Transplantation and cellular therapy

Published: November 09, 2025

Filters

An Azoreductase-Activated Self-monitoring Prodrug for Chemiluminescence Imaging and Safe Chemotherapy Breast Cancer.

An Azoreductase-Activated Self-monitoring Prodrug for Chemiluminescence Imaging and Safe Chemotherapy Breast Cancer.

High Cytotoxicity of Ruthenium(II) and Gold(I) Bimetallic Complexes and Its Precursors.

High Cytotoxicity of Ruthenium(II) and Gold(I) Bimetallic Complexes and Its Precursors.

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Safety and efficacy of G-CSF alone with pre-emptive plerixafor for autologous peripheral blood hematopoietic stem cell mobilization in newly diagnosed multiple myeloma.

Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.

Longitudinal ctDNA monitoring in patients with metastatic uveal melanoma undergoing isolated hepatic perfusion in combination with ipilimumab and nivolumab.

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

Allogeneic hematopoietic stem cell transplantation with high-dose melphalan and total body irradiation for hematological malignancies: a single-center retrospective analysis

How to approach the high-risk myeloma from induction through relapse?

How to approach the high-risk myeloma from induction through relapse?

Effect and safety of a conditioning regimen with chidamide and BEAM for autologous hematopoietic stem cell transplantation in lymphoma

Effect and safety of a conditioning regimen with chidamide and BEAM for autologous hematopoietic stem cell transplantation in lymphoma

Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response.

Targeting MCM6 Enhances Melphalan Chemosensitivity in Retinoblastoma by Modulating DNA Damage Response.

NGS-based monitoring of secondary acute lymphoblastic leukemia dynamics following lenalidomide maintenance in multiple myeloma patients.

NGS-based monitoring of secondary acute lymphoblastic leukemia dynamics following lenalidomide maintenance in multiple myeloma patients.

Busulfan and melphalan (Bu-Mel) versus carboplatin, etoposide, and melphalan (CEM) conditioning regimens for autologous haematopoietic stem cell transplant in children and young adults with high-risk neuroblastoma.

Busulfan and melphalan (Bu-Mel) versus carboplatin, etoposide, and melphalan (CEM) conditioning regimens for autologous haematopoietic stem cell transplant in children and young adults with high-risk neuroblastoma.

The efficacy of topotecan versus topotecan combined with melphalan in the treatment of vitreous seeds in retinoblastoma

The efficacy of topotecan versus topotecan combined with melphalan in the treatment of vitreous seeds in retinoblastoma

Tandem conditioning-based myeloablative HSCT for pediatric patients with refractory myeloid leukemias.

Tandem conditioning-based myeloablative HSCT for pediatric patients with refractory myeloid leukemias.